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Abstract 
We report an electrochemical method for measuring the activity of proteases using nanoelectrode 
arrays (NEAs) fabricated with vertically aligned carbon nanofibers (VACNFs). The VACNFs of 
~150 nm in diameter and 3 to 5 µm in length were grown on conductive substrates and 
encapsulated in SiO2 matrix. After polishing and plasma etching, controlled VACNF tips are 
exposed to form an embedded VACNF NEA. Two types of tetrapeptides specific to cancer-
mediated proteases legumain and cathepsin B are covalently attached to the exposed VACNF tip, 
with a ferrocene (Fc) moiety linked at the distal end. The redox signal of Fc can be measured 
with AC voltammetry (ACV) at ~1 kHz frequency on VACNF NEAs, showing distinct 
properties from macroscopic glassy carbon electrodes due to VACNF’s unique interior structure. 
The enhanced ACV properties enable the kinetic measurements of proteolytic cleavage of the 
surface-attached tetrapeptides by proteases, further validated with a fluorescence assay. The data 
can be analyzed with a heterogeneous Michaelis-Menten model, giving “specificity constant” 
kcat/Km as (4.3  0.8) x 10
4
 M
-1
s
-1
 for cathepsin B and (1.13  0.38) x 10
4
 M
-1
s
-1
 for legumain. 
This method could be developed as portable multiplex electronic techniques for rapid cancer 
diagnosis and treatment monitoring. 
Keywords: nanoelectrode array, legumain, cathepsin B, enzymatic kinetics, AC voltammetry 
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Introduction 
Proteases, the proteolytic processing proteins, are ubiquitous in living organisms and regulate a 
multitude of cellular processes including the cell cycle, hormone activation, apoptosis and 
angiogenesis.
1-3
 The cysteine protease legumain, also known as asparaginyl endopeptidase 
(AEP), has a strict specificity for hydrolysis of asparaginyl bonds.
4
 It is highly expressed in 
macrophages, on the cell surfaces and membranous vesicles in the metastatic and invasive solid 
tumors where it activates other proteases such as cathepsin B, H and L, that have both 
elastinolytic and collagenolytic activities.
5-7
 In breast cancer, several recent studies have shown 
that absence of the cysteine protease inhibitor leads to increased growth and metastasis.
8
 
However, overexpression of those cysteine proteases was not found in the normal tissue. Thus, 
rapid detection of the presence and activity of cancer-mediated proteases (i.e. legumain and 
cathepsin B), should be developed for enhancement of treatment.
9
 
Traditional methods for enzyme activity study include gel electrophoresis, high-performance 
liquid chromatography (HPLC), enzyme-linked immunosorbent assay (ELISA) and optical 
methods.
10-13
 These methods require specific synthesis of peptides, fluorescent labels and 
sophisticated instrumentations, which are high-cost and time-consuming. Radioimmunoassay 
(RIA) had been widely used as an highly sensitive detection method but is diminished nowadays 
due to health safety and environment concerns.
14
 Simple rapid electronic and/or electrochemical 
methods to detect enzyme activities are thus important in developing portable systems for point-
of-care diagnosis and treatment monitoring of diseases such as cancers. Recently, 
electrochemical methods using cyclic voltammetric (CV) measurements of redox-labeled 
peptides attached on macroscopic gold electrodes have been demonstrated in detecting high-
activity proteases such as trypsin, thrombin and plasmin.
15-16
 Due to the localized sensing 
mechanism, an array of electrodes functionalized with different peptides could potentially detect 
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multiple enzymes in a small sample volume. However, electrochemical detection of proteases 
that are more relevant to cancers, such as legumain and cathepsin B, has not been reported. These 
enzymes have much lower catalytic activity, making the measurement more difficult.  Here we 
focus on a new electrochemical technique enabled by nanostructured electrodes that can 
successfully detect these enzymes. 
It is well known that reducing the electrode size can dramatically enhance the detection 
sensitivity and temporal resolution of electrochemical measurements.
17-18
 This trend extends 
from the scale of microns to nanometers. Well-separated nanoelectrode arrays (NEAs), either in 
regular pattern or in random distributions (also referred to as nanoelectrode ensembles (NEEs)), 
have attracted extensive interests for highly sensitive electroanalysis, measuring fast 
electrochemical kinetics, and biosensing.
19-21
 Fabrication methods such as nanosphere 
lithography and E-beam lithography have been developed for the well-ordered NEAs.
22-23
 Carbon 
based NEAs are particularly attractive for biosensors due to the wider applicable potential 
window and ease in biofunctionalization through robust covalent attachment. Development in 
this area, however, has been limited by the lack of readily available methods to fabricate reliable 
NEAs. Recent research in carbon nanotechnology has provided a method to fabricate well-
controlled NEAs using vertically aligned carbon nanofibers (VACNFs) embedded in insulating 
materials.
24-26
 Both precisely patterned and randomly distributed carbon nanofibers (CNFs) with 
the average diameter of 50–200 nm and uniform vertical alignment have been fabricated on 4” Si 
wafers
27
 and can be mass-produced into robust NEAs on individually addressed microelectrodes 
forming an “array-in-array” format. Various applications of VACNF NEAs with and without 
further encapsulation of insulating materials have been demonstrated for various biosensing or 
biomedical applications, including DNA hybridization analysis,
28
 glucose detection,
25
 
electrochemical sensing of neurotransmitters,
29
 neural electrical recording,
30
 and gene delivery.
31
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Here we employ the embedded VACNF NEAs for enzymatic studies. The SiO2 matrix was 
selectively etched by plasma etching to expose ~50–200 nm long CNF tips over the surface (as 
shown in Figure S1 in supporting Information). Specific peptide substrates were functionalized at 
the exposed CNF tips and subjected to proteolysis by proteases. The small radius of the CNF tips 
(~50–100 nm) protruding over the SiO2 matrix makes it easier for enzymes to access to the 
peptides,  avoiding the steric hindrance that is normally encountered on macroscopic surfaces. 
Generally, CV measurements of bulk redox species using embedded VACNF NEAs show 
characteristic sigmoidal curves,
28,32
 in which the tiny CNF tips carry much higher current 
densities than macro- or micro-electrodes. This feature indicates one of the predicted benefits of 
nanoelectrodes due to the nonlinear radial diffusion of redox species to the electrode surface.
33
 
The NEA also presents much smaller electrochemical cell time constant which allows the 
electrochemical measurement to be carried out at a much higher speed. These properties make 
NEAs attractive for rapid high-sensitivity biosensing applications.  
Recently, we discovered that the electrochemical measurements on VACNF NEAs can be 
significantly improved by applying an alternating current (AC) voltage bias on the direct current 
(DC) ramps in the common CV measurement, i.e. by using AC voltammetry (ACV).
34
 An 
anomalously high electron transfer rate was obtained with redox-active Fc molecules attached to 
the exposed CNF tips of the embedded NEAs.
34
 This was attributed to the unique conically 
stacked graphitic structure of the CNFs, which opened a new capacitive pathway for AC current. 
As a result, ACV on VACNF NEAs can be carried out at much higher AC frequency (at kHz) 
than <100 Hz on macroscopic glassy carbon electrodes (GCEs). Since the magnitude of the 
signal in ACV, i.e. AC current amplitude, increases monotonically with the AC frequency at < 1 
kHz, the detection sensitivity can be greatly enhanced using VACNF NEAs. The ACV is 
particularly advantageous over common CV for measuring small quantities of surface-attached 
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redox molecules since the electrons can be shuffled back and forth for many times between the 
electrode and each adsorbed molecules. Here, we report the application of this property on 
detection of the enzymatic activities of legumain and cathepsin B by monitoring the kinetic 
decrease of the ACV signals of Fc attached to the CNF tip through a specific peptide linker 
during proteolysis. The data are well explained with the Michaelis-Menten heterogeneous 
enzymatic model. 
 
Experimental Section 
Apparatus and Reagents. The electrochemical measurements were conducted on a model 
440A electrochemical analyzer (CH Instruments, Austin, TX). Fluorescence assay was performed 
on GloMax-Multi+ Microplate Multimode Reader (Promega Corporation, Madison, WI). A 96-
well black polystyrene plate in the fluorescent measurement was from Whatman (Picataway, NJ). 
3-Aminopropyl-triethoxysilane (APTES), 2-(2-methoxyethoxy)ethoxyacetic acid, 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC), 1-hydroxy-2,5-dioxopyrrolidine-3-
sulfonic acid sodium salt (sulfo-NHS), sodium hydroxides, and 6-amino-1-hexanol were 
purchased from Sigma-Aldrich (Saint Louis, MO). 2-(4-Morpholino)ethane sulfonic acid (MES) 
and dithiothreitol (DTT) were purchased from Thermo Fisher Scientific (Fair Lawn, NJ). 
Recombinant human legumain/asparaginyl endopeptidase (molecular weight of 49 kDa) and 
recombinant human cathepsin B (molecular weight of 29 kDa) were acquired from R&D 
Systems Inc. (Minneapolis, MN). Before use for enzymatic reactions, legumain was activated in 
an activation buffer, consisting of 50 mM CH3COONa (pH 4.0, adjusted by adding acetic acid) 
and 100 mM NaCl. Cathepsin B was activated in an activation buffer of 5 mM DTT and 25 mM 
MES (pH 5.0). Substrates Z-Ala-Ala-Asn-AMC and Z-Leu-Arg-AMC for fluorescence assay 
were obtained from Bachem (Torrance, CA). All aqueous solutions were prepared using 18.2 
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MΩ-cm resistivity deionized (DI) water from a bench-top water purifier (Barnstead EASYpure II 
RF/UV, Model D7035, Thermo Scientific, Asheville, NC). 
Synthesis of Ferrocene-appended Tetrapeptides for Enzyme Cleavage. Ferrocene-
appended tetrapeptide for legumain cleavage (i.e. H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NH-CH2-
Fc) was synthesized following a sequence of reactions described in Figure S2.  In brief, H-Leu-2-
ClTrt-resin (Peptide International Inc., Louisville, KY) was converted to H-Ala-Ala-Asn-Leu-2-
ClTrt-resin using a microwave peptide synthesizer (CEM Inc., Matthews, NC) by the sequence of 
reactions: (1) coupling with Fmoc-Asn-OH, O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium 
hexafluorophosphate (HBTU), and diisopropylethylamine (DIEA) in DMF; (2) removal of the 
Fmoc protecting group with 20% piperidine in DMF; and (3) similarly, coupling with Fmoc-Ala-
OH and removal of Fmoc twice using the same reagents as described above.  H-Ala-Ala-Asn-
Leu-2-ClTrt-resin was cleaved with trifluoroacetic acid (TFA), triisopropylsilane (TIPS), and 
water (95:2.5:2.5) to give H-Ala-Ala-Asn-Leu-OH, which upon protection of the amino function 
with di-t-butyl dicarbonate (Boc2O) followed by the coupling with aminomethylferrocene
35
 and 
2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) 
afforded Boc-Ala-Ala-Asn-Leu-NHCH2Fc. Deprotection of the aforementioned tetrapeptide 
ferrocene with 10% TFA in dichloromethane at 25
o
C for 30 minutes, followed by condensation 
with N-Boc-5-aminovaleic acid and HATU in DMF, and removal of the Boc protecting group 
with 10% TFA in dichloromethane furnished H2N-(CH2)4CO-Ala-Ala-Asn-Leu-NHCH2-Fc. 
Ferrocene-labeled tetrapeptide substrate for cathepsin B cleavage (i.e. H2N-(CH2)4-CO-Leu-Arg-
Phe-Gly-NH-CH2-Fc) was synthesized using a synthetic scheme similar to the aforementioned 
one and the details are described in Figure S3. 
Fabrication of VACNF NEAs. The NEAs were fabricated by encapsulating VACNFs in SiO2 
matrix on a silicon chip using a similar method described in previous papers.
24,36
 Briefly, 
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VACNFs of an average length of ~5 μm were grown on ~100 nm Cr coated Si substrate using a 
DC-biased plasma enhanced chemical vapor deposition (PECVD) system (Aixtron, CA). A thin 
nickel film of ~22 nm was used as the catalyst to promote CNF growth. The electric field helped 
to align the CNF vertically on the substrate surface. Cross-sectional SEM images indicate that 
about 90% of the CNF have the length of 4 to 6 microns. The CNFs have the diameter distributed 
from ~100 to 200 nm and are well separated from each other, with an average distance of ~300 to 
400 nm. Dielectric SiO2 was deposited using chemical vapor deposition (CVD) from vapor-
phase precursor tetraethylorthosilicate (TEOS) to fully encapsulate the bottom Cr metal contact 
layer and each individual CNFs. Mechanical polishing was applied using 0.3 μm alumina slurry 
to produce a flat surface. Reactive ion etching (RIE) with a mixture of CHF3 and O2 gases was 
then performed with NRE-3000 (Nano-Master Inc., Austin, TX) to selectively etch away desired 
amount of SiO2. It can be controlled to expose 20% to 60% of the CNF tips based on the length 
variation. A typical VACNF NEA in this study consists of randomly distributed CNF tips with an 
average CNF diameter of ~100–200 nm and an average spacing over ~1 µm (corresponding to a 
density of ~(1–10) x 107 CNFs-cm-2). As shown in Figure S1, the length of exposed CNF tips 
was controlled at ~50–300 nm by varying the RIE time to selectively remove SiO2. 
Electrode Pre-conditioning. Before each use, VACNF NEAs were further polished with 0.05 
µm γ-alumina slurry on napless polishing cloth (Buehler, Lake Bluff, IL) for 5–15 minutes, 
followed by rinsing with deionized water. The VACNF NEAs were then electrochemically 
activated by etching in 1.0 M NaOH solution using four cycles of CV in a potential range of -
0.10 V to 1.20 V (vs. Ag/AgCl (3 M KCl)) at a scan rate of 50 mV•s-1. 
Passivation of the SiO2 Surface of the VACNF NEA Chip. To reduce nonspecific 
adsorption, the SiO2 surface of the VACNF NEAs was first passivated with protective moieties 
containing ethylene glycol. The chip was immersed in an 8 g L
-1
 solution of APTES in ethanol 
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for 20 minutes to produce a primary amine derivatized surface. The chip was treated with 50 µL 
solution of 0.1 mM of 2-(2-methoxyethoxy)ethoxyacetic acid, 100 g L
-1
 of EDC and 50 g L
-1
 of 
sulfo-NHS, and incubated at room temperature for 2 hours in an enclosed chamber (Arrayit, CA). 
The carboxylic acid group of 2-(2-methoxyethoxy)ethoxyacetic acid formed an amide bond with 
the amino function on the chip surface, leaving ethylene glycol moiety covering the surface. The 
molecules attached to the CNF tips were then removed by electrochemical etching at 1.2 V (vs. 
Ag/AgCl (3 M KCl)) for 20 seconds in 1.0 M NaOH solution. This process regenerated clean 
CNF tips which contain abundant carboxylic acid functional groups.  
Functionalization of the VACNF NEA Chip. The tetrapeptide H2N-(CH2)4-CO-Ala-Ala-
Asn-Leu-NHCH2-Fc for legumain study or H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NH-CH2-Fc for 
cathepsin B study was covalently linked to the VACNF NEA by forming amide bond facilitated 
by EDC and sulfo-NHS. Typically, a solution of 10 L of 10 mM tetrapeptide mixed with 90 L 
of 10 g L
-1
 EDC and sulfo-NHS was applied onto the electrochemically activated VACNF NEA 
chip and incubated in the enclosed Arrayit chamber at room temperature for 2 hours. Control 
experiments and HPLC-MS characterization (see Supporting Information) confirmed that only 
the end –NH2 group of the tetrapeptide formed amide bond with the carboxylic acid group on the 
VACNF NEA. The –NH2 and NH functions in asparagine and arginine moieties in the peptide do 
not react with the carboxylic acid group under the reaction conditions. In order to stabilize the 
electronic signal, the CNF electrode surface was further dipped into a solution of 5 mL of 1 mM 
6-amino-1-hexanol containing 5 g L
-1
 EDC and 2 g L
-1
 sulfo-NHS so that the unreacted –COOH 
sites were linked with 6-aminohexanol. 
Electrochemical Measurements. The electrochemical measurements were performed in a 
TEFLON cell with a total volume of 250 µL. The cell was sealed against a VACNF NEA chip 
with a 3-mm i.d. O-ring in a three-electrode configuration with the VACNF NEA as the working 
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electrode, an Ag/AgCl (3M KCl) reference electrode and a coiled Pt wire as the counter 
electrode. The electrolyte solutions were consisted of 50 mM MES (pH = 5.0) and 250 mM NaCl 
for legumain experiment and 25 mM MES (pH = 5.0) for cathepsin B experiment. The average 
AC current was measured by applying an AC voltage bias on the DC staircase waveform with the 
potential sweeping from -0.05 to +0.65 V for legumain experiment and -0.1 V to +0.75 V for 
cathepsin B experiment, both at 10 mV•s-1 scan rate. The parameters including AC voltage 
amplitude and frequency were varied in specific experiments and specified as the results are 
presented in later sections.  
Validation of the Enzyme Activities with Other Biochemical Methods. The activities of the 
enzymes vary significantly from batch to batch and are very sensitive to the environment and 
storage conditions. To reduce the errors, all enzymes were first validated with an established 
fluorescence-based biochemical method before each electrochemical experiment. The legumain 
activity was measured with a kinetic fluorescence assay using a commercial substrate Z-Ala-Ala-
Asn-AMC which gave strong fluorescence after cleavage at the site between asparagine and 
AMC dye. The substrate Z-Leu-Arg-AMC was used in the fluorescence assay for cathepsin B 
activity measurement. The cleavage at the site between arginine and AMC dye released the AMC 
from quenching by the carbonyl group and showed increased fluorescence intensity.  
 
Results and Discussion 
The Design and Electrochemical Characterization of VACNF NEAs for Protease 
Detection. Scheme 1 shows the structure of an embedded VACNF NEA covalently attached with 
Fc-linked peptides at the exposed CNF tips. The Fc moiety at the distal end provides a reliable 
redox signal at ~0.25 V vs. Ag/AgCl (3M KCl) in ACV measurements. Upon supplied with the 
specific protease, the peptide is expected to be cleaved at the particular site. As a result, the Fc 
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moiety is released from the electrode surface into the bulk solution, causing the redox signal to 
decrease. The kinetic of the enzymatic reaction at the electrode surface will be monitored by 
continuously repeated ACV measurements. The advantage of this method is that the appended Fc 
moiety provides a characteristic faradaic signal which can be easily separated from the unstable 
nonfaradaic background and other interfering redox signals. The key for this method is that the 
Fc signal needs to be relatively large and stable over the period of the kinetic measurements (up 
to ~1 hour) and the ACV measurement at each point is fast enough to provide ~1 minute (or less) 
of temporal resolution. This may become challenging for enzymes requiring long peptide 
substrate sequences for specific recognition. The Fc signal involves electron transfer between Fc 
molecule and the electrode surface, which is highly sensitive to the Fc-surface distance and the 
molecular packing of the peptides on the electrode surface. Thus the electrochemical properties 
of Fc-linked peptide attached on VACNF NEAs need to be carefully characterized. 
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Scheme 1. Schematic diagram of the cleavage of Fc-linked tetrapeptides at the VACNF NEA tip 
by specific proteases. (a) A random VACNF array embedded in the SiO2 matrix. (b) Electron 
transfer from appended ferrocene at the distal end of the peptide to the underlying metal film 
electrode through the VACNFs and the loss of the electrochemical signal from ferrocene due to 
the cleavage of the peptide at specific sites.  
 
Figure 1 shows the comparison of ACVs of a macro-GCE and a VACNF NEA, both 
functionalized with the tetrapeptide H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NHCH2-Fc to be used for 
legumain study. A peak current was observed at ~0.2 V vs. Ag/AgCl (3M KCl) for both 
electrodes. The amplitude of the peak current density (ip) in the ACVs with macro-GCE 
increased from ~1.0 x 10
-7
 A•mm-2 at 10 Hz to ~2.0 x 10-7 A•mm-2 at 40 Hz, but then dropped to 
zero at 1500 Hz. At the meantime, the background signal steadily increased from ~4.7 x 10
-7
, to 
1.8 x 10
-6
 and 2.8 x 10
-6
 A•mm-2, respectively. In contrast, although the ip of ACV with VACNF 
NEAs was not measurable at 10 Hz and 40 Hz, it rose clearly above the background at 1500 Hz, 
giving ~2.0 x 10
-8
 A•mm-2. Obviously, VACNF NEAs allowed the Fc signal to be detected at 
much higher frequency. It is noteworthy that the current density in Figure 1 was calculated with 
the geometric electrode surface area. As shown in Figure S1, the actual exposed CNF surface 
area in the VACNF NEA is more than ~100 times less than the geometric surface area. Hence the 
real current density at the CNF tip is at least 10 times higher than that at the GCE. Generally, the 
electrochemical signal is very sensitive to Fc-surface distance since the electron transfer rate 
decays exponentially versus the Fc-surface distance. Hence electrochemical sensors based on 
redox reactions normally use linker molecules less than 2 nm in length. Here, the electron 
transfer on both GCEs and VACNF NEAs was not significantly affected by the tetrapeptide and 
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the linker (with a fully extended length of ~2.5 nm). Experiments with an even longer 
octapeptide (to be published) did not show notable difference in Fc signal, suggesting that the 
molecule might be folded back to the CNF surface.  
 
Figure 1. Comparison of AC voltammograms (ACVs) measured at 10, 40 and 1500 Hz of H2N-
(CH2)4-CO-Ala-Ala-Asn-Leu-NHCH2-Fc immobilized on a macro-GCE (a–c) and on a VACNF 
NEA (d–f). All the measurements were done in 500 µL of 50 mM MES (pH 5.0) and 250 mM 
NaCl. Sinusoidal waves with the fixed amplitude of 25 mV were superimposed on a DC staircase 
ramp from -0.05 to +0.65 V at a scan rate of 10 mV•s-1. The measured average AC current at 
each point was normalized by the 7.1 mm
2
 geometric surface area defined by the 3-mm i.d. O-
ring. The actual CNF surface area is ~100 times less. 
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ACV uses a sinusoidal AC voltage superimposed on a DC potential ramp for voltammetric 
measurements. It has advantages over commonly used DC-based CV, particularly for biosensors, 
due to the ability to amplify the electrochemical signal of small quantity of redox tags by 
shuffling the electron between the redox tag and the electrode many times. In general, the signal 
increases with AC frequency at low frequencies but is saturated and then decreases at higher 
frequencies. In our previous study using VACNF NEAs, the optimum frequency for Fc through a 
short NH2CH2- linker was found to be 40 times higher than that on the macro-GCE.
34
 Figure 2 
illustrates the similar phenomena with Fc attached to the electrode surface through the 
tetrapeptide and a longer linker group versus the AC frequency. Clearly, the optimum frequency 
which gave the maximum ip was 40 Hz for the GCE, but 1750 Hz for the VACNF NEA. Despite 
that both frequency values are about half of those with short NH2CH2- linker, the drastic 
difference between VACNF NEA and macro-GCE remained the same, i.e. the optimum 
frequency on the VACNF NEA was ~40 times of that on the GCE. The higher applicable AC 
frequency at VACNF NEA afforded a larger ACV signal (i.e. ip) and faster ACV measurements. 
Each ACV measurement in Figure 1 can be done in ~60–70 s. As a result, the kinetics of 
enzymatic cleavage can be monitored with continuously repeated ACV measurements at a 
temporal resolution of ~1 minute. 
The AC peak current density ip,acv can be extracted by subtracting the background (as a simple 
sloped straight line). These values are plot in Figure 2a versus the AC frequency. Clearly, the AC 
peak current density of the GCE shows a sharp peak with the maximum at 40 Hz and a full width 
at half maximum (FWHM) of ~140 Hz. The current value approximately increases linearly with 
the AC frequency but drops rapidly as the AC frequency exceeds 40 Hz. In contrast, the 
maximum AC peak current density was observed at 1750 Hz on the VACNF NEA and the 
FWHM asymmetrically spread over 5000 Hz, indicating a large range of frequency that can be 
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used. The current density increases about linearly with the frequency up to ~1000 Hz. When the 
peak current density is plot versus the logarithm of the AC frequency as shown in Figure 2b, the 
curves obtained with the GCE and the VACNF NEA show similar shape but with shifted peak 
frequency. It needs to be noted that the ACV measurements are not stable with the GCE. The 
peak shape changed significantly in about 10 minutes as shown in Figure S4, which limits the use 
of GCEs for the measurement of enzymatic kinetics. In contrast, the peak shape of the ACV 
curve of VACNF NEAs is much more stable. 
 
Figure 2. (a) Background-corrected ACV peak current density ip,acv (normalized to the 7.1 mm
2
 
geometric electrode area) of  H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NHCH2-Fc immobilized on a 
GCE (square) and a VACNF NEA (filled circle) plotted against the AC frequency. (b) Plot of 
ip,acv versus logarithm of the AC frequency. Note: The real CNF surface area is ~100 times less 
than the geometric surface area defined by the O-ring. 
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Figure 3. Background-corrected ACV peak current density ip,acv (normalized to the 7.1 mm
2
 
geometric electrode area) of  H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NHCH2-Fc immobilized on a 
GCE and a VACNF NEA plotted against the amplitude of the AC voltage (square: GCE, filled 
circle: VACNF NEA).  
 
The peak current in ACVs also depended on the amplitude of the applied AC voltage. Figure 3 
shows that there is a small difference between the GCE and the VACNF NEA. The peak current 
density (ip,acv) reached to the highest value of ~1.5 x 10
-6
 A•mm-2 at the amplitude of 0.35 V for 
GCE while the peak current density kept increasing at the amplitude up to 0.50 V for VACNF 
NEA. However, for the VACNF NEA at amplitude larger than 0.15 V, the value of the peak 
current density deviated from the linear relationship and the raw ACV peak became broad and 
unstable (Figure S5). For this reason, we choose amplitude at 0.15 V as the optimum working 
amplitude in all the following ACV measurements for legumain activity study. For cathepsin B 
study, the tetrapeptide H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NH-CH2-Fc was immobilized on the 
VACNF NEA, giving very similar ACV properties with slightly different optimum AC frequency 
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(800 Hz) and amplitude (0.15 V), respectively (see Figure S6). These optimum parameters were 
used in the following kinetic study on cathepsin B activities.  
 
Figure 4. (a) The change of the peak current (ip,acv) of H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NH-
CH2-Fc immobilized on a VACNF NEA in continuously repeated ACV measurements while 25 
µL of 9.8 ng•µL-1 (338 nM) cathepsin B in the activation buffer consisting of 5 mM DTT and 25 
mM MES (pH 5.0) was added into the electrochemical cell containing 250 µL of 25 mM MES 
(pH 5.0). All ACV measurements were carried out at f = 800 Hz and AC voltage amplitude V0 = 
150 mV. (b) ACV curve measured at the time of 20 minute immediately after the cathepsin B 
solution was added into the electrochemical cell. (c) Five representative background-subtracted 
ACV curves measured at 20 (black), 25 (red), 30 (blue), 40 (green) and 75 minute (pink), 
respectively, showing the decrease of ip, acv due to enzymatic cleavage 
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Figure 4a shows the change of peak current (ip,acv) over time during continuously repeated 
ACV measurements with Fc-linked tetrapeptide (H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NH-CH2-
Fc) immobilized on a VACNF NEA. The initial signal was quite stable, with only slow drifting. 
At ~20 minute, a solution of 25 µL of 9.8 ng•µL-1 (338 nM) cathepsin B in the activation buffer 
was added into the electrochemical cell, giving a final enzyme concentration of 30.7 nM. Due to 
the disturbance to in electrolyte, the ACV peak current jumped up and then followed by an 
exponential decay. Figure 4b shows the ACV curve measured at 20 minute, immediately after the 
cathepsin B solution was added. A clear peak at around 0.25 V confirms the immobilization of 
Fc-linked tetrapeptide on the electrode surface. Figure 4c further illustrates the representative 
background-subtracted ACV curves corresponding to 0, 5, 10, 20 and 55 minutes, respectively, 
after adding the cathepsin B solution. The peak current clearly decreased over time and the peak 
position slowly shifted from 0.27 V to 0.18 V. Two control experiments (Figure S7) were carried 
out and confirmed that the exponential decay in ip,acv was truly attributed to the kinetics of 
enzymatic cleavage of the peptide. First, 25 µL of blank activation buffer, i.e. 5 mM DTT and 25 
mM MES (pH 5.0), was added into the electrochemical cell prefilled with 250 µL of electrolyte 
(25 mM MES (pH 5.0)). The disturbance to the ACV signal was negligible in this process. 
Second, a solution of 25 µL of activation buffer containing deactivated cathepsin B (which was 
confirmed with the fluorescence assay) was added into the electrochemical cell in the similar way 
as in the first case. Neither case showed the characteristic exponential decay observed when the 
activated enzyme was introduced. It is clear that the exponential decay was due to enzymatic 
cleavage to the tetrapeptide substrate by cathepsin B.  
The observed proteolysis kinetics may be explained with a modified Michaelis-Menten model 
for heterogeneous enzymatic reactions:
37
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where E, Ss, ESs, Ps and P represent the enzyme, the surface-bound peptide substrate, the 
enzyme-substrate complex on the electrode surface, the surface-attached product, and the product 
released to solution, respectively. The reaction rate can be defined as 
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where kcat is the dissociation rate constant, Km = (kcat+k-1)/k1 is the Michaelis-Menten constant, 
and Ss and Ps represent the surface densities of original and reacted peptide substrates, 
respectively. At low enzyme concentrations with [E0] << Km, an approximate relationship can be 
obtained as  
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The reaction rate  (or -dSs/dt) is a time-dependent quantity proportional to the change in 
electrochemical signals (dS/dt), where S is the kinetic electrochemical signal corresponding to the 
peak current ip in ACV measurements. As a result the slope of (dS/dt) versus the time-dependent 
Ss will be equal to (kcat/Km)[E0], namely 
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Thus, by rearranging the kinetic electrochemical data, we can derive the value of “specificity 
constant” kcat/Km which is commonly used to represent the catalytic efficiency of enzymes.  
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Figure 5. Replot of the data presented in Figure 4. (a) Decrease of the quantity of surface 
adsorbed Fc (i.e. surf) during enzymatic cleavage of the tetrapeptide after adding the cathepsin B 
solution. (b) Plot of the reaction rate (vi) versus the quantity of surface adsorbed Fc (surf) during 
the enzymatic reaction.  
To further analyze the kinetic enzymatic process, the peak current in ACV was converted into 
the quantity of surface adsorbed Fc (i.e. surf) based on
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where the AC frequency f was 800 Hz and the amplitude of the AC voltage V0 was 150 mV. 
Although the surf value derived with Equation 5 is known to be smaller than that obtained with 
other methods, particularly at high frequencies, the linear relationship between ip,acv and surf 
remains true. The deviation of the proportional coefficient from the true value iscancelled in later 
steps and does not affect the final results. As shown in Figure 5a, the kinetic data can be fitted 
with an exponential decay superimposed on a linear curve corresponding to the slow baseline 
drift. The fitting equation is  
15196.683
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From equation 6, the reaction rate vi at different surf can be calculated. The results were 
presented in Figure 5b, which appeared to be a linear curve in the high surf region. This linear 
curve is fitted by equation 
                                               
183 1020.11015.1   surfiv  .     (7) 
As mentioned earlier, both vi and surf are proportional to ip,acv. The slope of vi versus surf, 
however, is independent of the exact proportional coefficient since it presented in both vi and 
surf and is thus cancelled. Therefore, we can derive the exact slope without being affected by the 
ACV experimental conditions. Equation 7 gives a slope of 1.15 x 10
-3
 s
-1
, which equals to 
(kcat/Km)[E0] as described in Equation 3. With [E0] = 30.7 nM, the value of the “specificity 
constant” kcat/Km can be calculated as 3.8 x 10
4
 M
-1
s
-1
. This value is close to the value of 2.3 x 
10
4
 M
-1
s
-1
 derived from the comprehensive analysis with the fluorescence assay in a series of 
peptide substrate concentrations (Figures S8 and S9). It is also within the range reported in 
literature which varies from ~2 x 10
3
 M
-1
s
-1
 to ~7 x 10
6
 M
-1
s
-1
. 
37, 39-40
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Figure 6. (a) The change of the peak current (ip,acv) of H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NH-
CH2-Fc immobilized on a VACNF NEA in continuously repeated ACV measurements while 11 
µL of 90.9 ng µL
-1
 (1.90 µM) legumain in the activation buffer consisting of 50 mM CH3COONa 
(pH = 4.0, adjusted by adding acetic acid) and 100 mM NaCl was added into the electrochemical 
cell containing 250 µL of 50 mM MES (pH 5.0) and 250 mM NaCl. All ACV measurements 
were carried out at f = 1750 Hz and AC voltage amplitude V0 = 150 mV. (b) Replot of the data 
presented in figure (a) showing the reduction of the quantity of surface adsorbed Fc (i.e. surf) 
during enzymatic cleavage of the tetrapeptide after adding the legumain. (c) Plot of the reaction 
rate (vi) versus the quantity of surface adsorbed Fc (surf) during the enzymatic reaction. 
 
Figure 6 shows the ACV measurements with H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NH-CH2-Fc 
immobilized on a VACNF NEA. Comparing to cathepsin B, the change of peak current 
corresponding to the cleavage by legumain was smaller, likely due to the difference in the 
enzyme activity. None of the two control experiments in Figure S10 by adding the blank 
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activation buffer and the buffer containing deactivated legumain (confirmed with fluorescence 
assay), respectively, showed the characteristic exponential decay in ip,acv. The former caused 
negligible disturbance to the electrochemical signal. The latter caused the ip,acv to slowly rise by 
~5% after 5 minutes and then became stabilized, which might be attributed to the  disturbance to 
the tetrapeptide conformation on the electrode surface. 
The data in Figure 6b can be fitted with the following equation: 
15201101
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where the time constant is 1101 s (~18 min.), indicating that the reaction is quite slow. It 
normally took ~1 hour to complete the kinetic measurement. This was found to be limited by the 
low enzymatic activity of legumain. However, it was still possible to extract the faradaic signal 
of Fc from the varying background with the ACV measurements. Figure 6c gives a linear curve 
fitted by equation 184 1030.21030.6   surfiv with the slope of 6.30 x 10
-4
 s
-1
 at [E0] = 80.1 
nM. From this analysis, the value of the kcat/Km can be calculated as 7.9 x 10
3
 M
-1
s
-1
. This value 
is higher than the value of 4.3 x 10
3
 M
-1
s
-1
 derived from the comprehensive analysis using the 
fluorescence assay (Figures S11 and S12) and the specifications provided by the vendor (R&D 
Systems).  
The kinetic measurements with ACV for both cathepsin B and legumain were repeated at least 
three times under similar conditions as those in Figure 4 and Figure 6. The results were 
consistent and reproducible. More comprehensive measurements at varied enzyme concentrations 
and peptide lengths will be reported in future studies. Table 1 summarizes the statistical values of 
the specificity constant kcat/Km derived from both electrochemical method using ACVs on 
VACNF NEAs in comparison with the fluorescence assay based on a series of substrate 
 24 
concentrations in solution, for both legumain and cathepsin B. Interestingly, the electrochemical 
method gave higher kcat/Km values for both of legumain and cathepsin B than the fluorescence 
assay. In contrast, other studies using macroscopic electrodes found that the electrochemically 
measured kcat/Km was normally lower than solution based assays, primarily due to the steric 
effects which lower the access of enzyme to the peptides attached to the flat surface.
15-16
 The 
results confirmed that the small radius in VACNF NEAs helped to eliminate the steric hindrance. 
The peptide substrates for the fluorescence assay consisted of only 3 and 2 amino acids, 
respectively, which were also expected to have lower binding affinity than the tetrapeptides used 
for our electrochemical measurements.  
 
Table 1. Comparison of the specificity constant kcat/Km for legumain and cathepsin B, derived 
from the electrochemical method (i.e. ACV on VACNF NEAs) and the fluorescence assay in 
solutions.  
Enzyme Peptide Sequence kcat/Km (M
-1
s
-1
) 
Legumain 
(FL
a
) Ala-Ala-Asn-AMC (4.3 ± 0.6) x 10
3
 
(EC
b
) Ala-Ala-Asn-Leu-NH-CH2-Fc (11.3 ± 3.8) x 10
3
 
Cathepsin B 
(FL) Leu-Arg-AMC (2.3 ± 1.7) x 10
4
 
(EC) Leu-Arg-Phe-Gly-NH-CH2-Fc (4.3 ± 0.8) x 10
4
 
    
a
FL: fluorescence; cleavage siteThe fluorescence data were derived from the analysis in 
Figures S8, S9, S11 and S12. 
b
EC: electrochemistry. The electrochemical data were statistical value over at least duplicated 
experiments. 
 
The values of the specificity constant kcat/Km for cathepsin B by both electrochemical and 
fluorescence assays are about 5 times of that of legumain. For ACV measurements, this helps to 
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reduce the time constant for the exponential decay and makes the experiment easier and more 
reliable. As a result, lower enzyme concentration can be measured. From these results, it can be 
concluded that the ACV would work even better for measuring proteases with the kcat/Km values 
higher than ~4 x 10
4
 M
-1
s
-1
. But even proteases with relatively low specificity constant (such as 
legumain and cathepsin B) can still be reliably measured. Even though the required enzyme 
concentration was ~5 to 10 times higher than that by the fluorescence assay, the electrochemical 
method has a potential advantage that simultaneous detection of multiple proteases in a small 
volume is possible, attributed to its localized sensing mechanism using surface-attached peptides. 
Further investigation is in progress to assess the cross-reactions between different enzyme-
substrate pairs. 
The vendor suggests that legumain cleaves peptide bonds with asparagine (Asn) at the P1 
position while it has been reported that cathepsin B cleaves peptide or AMC bonds with arginine 
(Arg) at P1 site.
41
 To confirm the cleavage site, we have incubated each tetrapeptide with 
legumain and cathepsin B and measured the products with HPLC. As shown in Figure S13 and 
Figure S14, the HPLC graphs of the cleaved products were directly compared with those of the 
pure tetrapeptides and synthesized fragments (mono amino acid or dipeptide). The cleaved 
products were further validated with mass spectrometry. These experiments clearly demonstrated 
the cleavage site as listed in Table 1. Interestingly, even after incubating for 2 hours, the cleaved 
tetrapepetide concentration was only ~1/5 of the total concentration for legumain and ~3/4 for 
cathepsin B. The fluorescence assay reported earlier is sensitive to the absolute amount of 
cleaved products while the electrochemical assay is sensitive to the percentage of the cleavage to 
the surface-attached peptide. The large amount of starting peptides used in the fluorescence assay 
partially contributed to its capability to measure lower enzyme concentrations. The 
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electrochemical method, however, has advantage for miniaturization and multiplexing which 
may be critical for rapidly screening multiple proteases in disease diagnosis. It is noteworthy that 
the kcat/Km values of legumain and cathepsin B are relatively low, but they have high biological 
significance respect to cancer diagnosis and treatment. The speed and required enzyme 
concentration in the electrochemical measurements can be significantly improved when this 
technique is used to detect other proteases with higher kcat/Km values, such as trypsin at (1.44 
0.1) x 106 M-1s-1,15 -thrombin at (1.0 0.2) x 106 M-1s-1,15 and plasmin at 6.7 x 105 M-1s-1.16 
In previous electrochemical detection of proteases including trypsin,
15
 a-thrombin,
15
 and 
plasmin,
16
 normal CV measurements on gold electrodes were used. This method was found not 
applicable on carbon electrode. As shown in Figure S15, the Fc redox waves of the labeled 
tetrapeptide can be observed on the GCE, but the baseline currents were quite high, making it 
difficult to reliably extract redox signals. The previous studies on gold electrodes were able to 
block the nonfaradaic background current using close-packed self-assembled monolayer of small 
passivating alkane thiol molecules. The covalent bond of small passivating molecules does not 
allow them to move around to form a close-packed monolayer.  Thus there were many leaking 
pinholes in the passivation layer on GCE. This is even more severe on VACNF NEA due to the 
curvature and inhomogeneity at the CNF surface. As a result, it was not possible to use CV to 
measure the Fc signal on VACNF NEAs. ACV provides a necessary solution for the reported 
enzymatic study.  
While we have demonstrated that it is feasible to detect the enzymatic kinetics of both 
legumain and cathepsin B. It remains critical to evaluate the specificity for any practical 
applications. This will be carefully investigated in the future. Our preliminary data indicated that 
the specificity of protease detection using this reported method strongly depended on the value of 
the “specificity constant” kcat/KM. Cathepsin B has higher kcat/KM which resulted in ~75% of drop 
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in the electrochemical signal due to cleavage to the designated tetrapeptide (see Figure 4). As a 
result, the exponential decay can be reliably measured, giving high specificity. In contrast, as 
shown in Figure S16, the change of electrochemical signal is negligible using a tetrapeptide 
without Arg. For legumain, the low value of kcat/KM caused that the electrochemical signal only 
dropped by ~10% (see Figure 6a). The disturbance to the electrode during adding the enzyme 
solution caused uncontrollable fluctuation in the electrochemical signal. This limited precisely 
deriving the kcat/KM value. Therefore, the specificity for legumain is inconclusive at this stage 
and needs careful further study. But we can conclude that kcat/KM of (1.13  0.38) x 10
4
 M
-1
s
-1
 (as 
for legumain) is about the low limit for reliable protease measurements using the current setup.  
 
Conclusions 
In summary, we have demonstrated that high-frequency ACV can be applied on embedded 
VACNF NEAs to measure the redox reaction of Fc attached to the exposed CNF tip through a 
tetrapeptide and linker molecule. Due to the additional capacitive current pathway enabled by the 
unique interior graphitic microstructure of the VACNFs, the optimum frequency giving the 
highest peak AC current for Fc on VACNF NEA was found to be 40 times of that on GCEs. The 
higher frequency afforded a larger ACV signal and shorter time for the each ACV measurements. 
Thus the kinetics of proteolysis of the surface-attached peptides can be measured upon addition 
of two types of cancer related proteases, i.e. legumain and cathepsin B. The kinetic process can 
be analyzed with a heterogeneous Michaelis-Menten model to derive the “specificity constant” 
kcat/Km, which is (4.3  0.8) x 10
4
 M
-1
s
-1
 for cathepsin B and (1.13  0.38) x 10
4
 M
-1
s
-1
 for 
legumain. These values are about 2 times of that measured with a fluorescence assay as well as 
the specifications provided by the vendor. The nanostructured electrode size clearly eliminated 
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the steric effects for enzymatic reactions with surface-attached peptides. This is the first example 
of the use of VACNF NEA on protease activity study. These VACNF NEA based 
electrochemical enzymatic biosensors can be potentially developed into portable multiplex 
electronic devices for rapid cancer diagnosis and treatment monitoring. Further study on the 
specificity and sensitivity of this VACNF NEA biosensor applied with biological samples is in 
progress toward this goal. 
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Figure S1. Field-emission scanning electron microscopy image at 45° perspective view shows that VACNFs of ~150 
nm in average diameter are encapsulated in SiO2 matrix leaving only the tips exposed.  
 
Figure S2. Synthesis of H2N-(CH2)4CO-Ala-Ala-Asn-Leu-NHCH2-Fc for legumain detection. 
 
Experimental Details for Figure S2: Synthesis of H2N-(CH2)4CO-Ala-Ala-Asn-Leu-NHCH2-Fc for legumain 
detection 
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Synthesis of tetrapeptide H-Ala-Ala-Asn-Leu-OH (Figure S2) using a CEM microwave 
peptide synthesizer.  Leucine chlorotrityl resin (0.54 mmol/g; 200 mesh) was purchased from 
Peptide International.  The standard coupling procedure is followed.  To 1 g (0.54 mmol) of resin 
was added a solution of Fmoc-amino acid (1.62 mmol, 3 equiv.) and HBTU (1.46 mmol, 2.7 
equiv.) in dry DMF (13 mL) containing 4.2 % diisopropylethyl amine. The mixture was 
subjected to microwave irradiation (25 W, 5 min, 75 
o
C) with stirring. The reaction mixture was 
filtered and washed with DMF (10 mL each, 5 times).  The standard procedure for the removal of 
Fmoc protecting group is followed.  A solution of 20 mL of 20% piperidine in DMF was added 
to the above resin and subjected to microwave irradiation (50 W, 3 min, 75 
o
C). The reaction 
mixture was filtered and washed with DMF (10 ml each, 5 times).  The standard procedure for 
cleavage of the peptide from resin is followed.  The above resin was washed with 
dichloromethane (20 mL) and mixed with 20 mL of a cleavage cocktail solution consists of 95% 
trifluoroacetic acid (TFA), 2.5% triisopropylsilane (TIPS), and 2.5% water.  The mixture was 
irradiated under a microwave reactor (20 W, 38 
o
C) for 18 min.  The reaction mixture was 
filtered into a 100 mL flask and diluted with 100 mL of cold hexane:ether (1:1) to precipitate out 
the desired peptide.  The solid peptide was collected by centrifugation (2500 rpm) and washed 
three times with cold hexane:ether (1:1) to give H-Ala-Ala-Asn-Leu-OH as white solids (95 mg). 
MS calcd for C16H30N5O6 (M+H)
+
 388.2, found 388.4. 
Synthesis of Boc-Ala-Ala-Asn-Leu-OH.  To a solution of H-Ala-Ala-Asn-Leu-OH (50 mg, 
0.13 mmol) were added triethylamine (36 μL, 0.26 mmol) and dioxane:water (1:1) (10 mL), and 
the resulting solution was stirred for 10 min. To it, di-t-butyl dicarbonate (Boc2O) (56 mg, 0.26 
mmol) was added and the solution stirred for 12 h at r.t.  The reaction solution was concentrated 
to dryness yielding Boc-Ala-Ala-Asn-Leu-OH as a white solid (60 mg; 96% yield). MS calcd for 
C21H37N5NaO8 (M+Na)
+
 510.3, found 510.4. 
Synthesis of Boc-Ala-Ala-Asn-Leu-NHCH2-Fc.  To a solution of Boc-Ala-Ala-Asn-Leu-OH 
(60 mg, 0.12 mmol) in DMF (2 mL) under argon was added HATU (47 mg, 0.12 mmol) and the 
solution was stirred for 10 min.  To it, aminomethylferrocene (26 mg, 0.12 mmol) was added, 
and the solution was stirred at r.t. for 2 h, filtered, and separated on a HPLC using a preparative 
column (Phenomenex-Jupiter C18) and eluting with 40% acetonitrile/water to 80 % 
acetonitrile/water over 40 min with a 10 ml/min flow rate.  The fractions containing the desired 
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product were combined and lyophilized to yield Boc-HN-Ala-Ala-Asn-Leu-NHCH2-Fc as a 
yellow solid (40 mg; 48% yield). MS calcd for C32H48FeN6NaO7 (M+Na)
+
 707.3, found 707.5. 
Synthesis of H2N-Ala-Ala-Asn-Leu-NHCH2-Fc.  Boc-Ala-Ala-Asn-Leu-NHCH2-Fc (18 mg, 26 
mol) was dissolved in 2 mL of 10% TFA in dichloromethane and stirred at r.t. for 30 min, 
concentrated gently on a rotovap to give a residue.  The residue was dissolved in deionized water 
(2 mL), frozen, and lyophilized to give H-Ala-Ala-Asn-Leu-NHCH2-Fc as a green solid (15 mg; 
100% yield).  MS calcd for C27H40FeN6NaO5 (M+Na)
+
 607.2, found 607.3. 
Synthesis of Boc-HN-(CH2)4CO-Ala-Ala-Asn-Leu-NHCH2-Fc.  To a solution of N-Boc-5-
aminovaleric acid (5.6 mg, 26 mol) in DMF (2 mL) was added HATU (9 mg, 24 mol), and the 
resulting solution was stirred at r.t. for 10 min. This solution was cannulated to tetrapeptide H-
Ala-Ala-Asn-Leu-NHCH2-Fc (10 mg, 17 mol), and the resulting solution was stirred for 2 h at 
r.t., filtered, and separated on a HPLC using a preparative column (Phenomenex-Jupiter C18) and 
eluting with 40% acetonitrile/water to 80 % acetonitrile/water over 40 min with a 10 ml/min flow 
rate.  The fractions containing the desired product were combined and lyophilized to yield Boc-
HN-(CH2)4CO-Ala-Ala-Asn-Leu-NHCH2-Fc as a yellow solid (6 mg; 45% yield). MS calcd for 
C37H57FeN7NaO8 (M+Na)
+
 806.4, found 806.5. 
HPLC method: (gradient elution), λ=254 nm 
Synthesis of H2N-(CH2)4CO-Ala-Ala-Asn-Leu-NHCH2-Fc.  Boc-HN-(CH2)4CO-Ala-Ala-Asn-
Leu-NHCH2-Fc (6 mg, 8 mol) was dissolved in 1 mL of 10% TFA in dichloromethane and 
stirred at r.t. for 30 min.  The reaction solution was concentrated gently on a rotary evaporator to 
give a residue which was dissolved in deionized water (2 mL), frozen and lyophilized to give 
H2N-(CH2)4CO-Ala-Ala-Asn-Leu-NHCH2-Fc as a green solid (4 mg; 75% yield).  MS calcd for 
C32H50FeN7O6 (M+H)
+
 684.3, found 684.4. 
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Figure S3. Synthesis of H2N-(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-Fc for cathepsin B detection. 
Experimental Details for Figure S3: Synthesis of H2N-(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-
Fc for cathepsin B detection 
Synthesis of tetrapeptide H2N-(CH2)4CO-Leu-Arg-Phe-Gly-OH (Figure S3) using a CEM 
microwave peptide synthesizer. The Glycine chlorotrityl resin (0.48 mmol/g; 200 mesh) was 
purchased from peptide international. The procedures for coupling, removal of Fmoc protecting 
group, and cleavage from the resin were identical to that described above for the synthesis of 
legumain substrate.  From 1.2 g (0.57 mmol) of Glycine chlorotritylresin, 0.32 g (94% yield) of 
H2N-(CH2)4CO-Leu-Arg-Phe-Gly-OH was obtained as a white solid.  MS calcd for C28H47N8O6 
(M+H)
+
 591.4, found 591.2. 
 
Synthesis of Boc-HN-(CH2)4CO-Leu-Arg-Phe-Gly-OH.  A solution of sodium bicarbonate (86 
mg, 1.2 mmol) and H2N-(CH2)4CO-Leu-Arg-Phe-Gly-OH (0.300 g, 0.5 mmol) in 30 mL of 
dioxane:water (1:1) was stirred at r.t. for 10 min. To it, di-t-butyl dicarbonate (Boc2O) (0.22 g, 
1.2 mmol) was added, and the solution stirred for 12 h, concentrated to dryness yielding a white 
solid (0.35 g; 99% yield).  MS calcd for C33H55N8O8 (M+H)
+
 691.4, found 691.7. 
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Synthesis of Boc-HN-(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-Fc.  A solution of Boc-
NH(CH2)4CO-Leu-Arg-Phe-Gly-OH (60 mg, 0.09 mmol) and HATU (47 mg, 0.12 mmol) in 
DMF (2 mL) was stirred at r.t. for 10 min.  To it, aminomethylferrocene (26 mg, 0.12 mmol) was 
added, and the solution was stirred for 2 h, filtered, and separated on a HPLC using a preparative 
column (Phenomenex-Jupiter C18) and eluting with 40% acetonitrile/water to 80 % 
acetonitrile/water over 40 min with a 10 ml/min flow rate.  The fractions containing the desired 
product were combined and lyophilized to yield Boc-HN-(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-
Fc as a yellow solid (40 mg; 50% yield). MS calcd for C44H66FeN9O7 (M+H)
+
 888.4, found 
888.6. 
Synthesis of H2N-(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-Fc.  A solution of Boc-HN-
(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-Fc (50 mg; 56 mol) in 2 mL of 10% TFA in 
dichloromethane was stirred at r.t. for 30 min, concentrated gently on a rotary evaporator, 
dissolved in deionized water (2 mL), frozen, and lyophilized to give H2N-(CH2)4CO-Leu-Arg-
Phe-Gly-NHCH2-Fc as a green solid (43 mg; 98% yield). MS calcd for C39H58FeN9O5 (M+H)
+
 
788.4, found 788.5. 
Verification of the inactivity of the guanidine NH function of arginine residue of Boc-HN-
(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-Fc.  The following reaction has been carried out to verify 
that the guanidine NH function of arginine residue of Boc-HN-(CH2)4CO-Leu-Arg-Phe-Gly-
NHCH2-Fc does not form amide bond with the carboxylic function on carbon nanofibers. To a 1 
mL aqueous solution of Boc-HN-(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-Fc (3 mg, 3.4 μmol), 
benzoic acid (0.4 mg, 3.4 μmol), and N-hydroxysuccinimide (0.4 mg, 3.4 μmol) was added with 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.66 mg, 3.4 μmol), and the 
resulting solution was stirred at room temperature for 2 hours. Mass spectrometry analysis 
showed that no reaction took place between the NH group of arginine residue and the carboxylic 
acid moiety of benzoic acid. Boc-HN-(CH2)4CO-Leu-Arg-Phe-Gly-NHCH2-Fc remained 
unchanged.  The test suggested that the NH moieties in the side chain of arginine residue does 
not react with the carboxylic acid function of carbon nanofibers. The most likely route for the 
peptide to be attached to the VACNF NEA is by forming the amide bond through the –NH2 
group at the distal end of the linker (as shown in Figure S3). 
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Figure S4. The ACV of H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NH-CH2-Fc immobilized on the GCE (a) from the initial 
measurement and (b) from the measurement after 20 minutes. The AC frequency was 30 Hz and the amplitude was 
25 mV. The measurement was done in 250 µL of 25 mM MES solution (pH 5.0).  
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Figure S5. Comparison of AC voltammograms (ACVs) of H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NH-CH2-Fc 
immobilized on a macroscopic glassy carbon electrode (GCE) (a–c) and a VACNF NEA (d–f) at the AC voltage 
amplitude of 0.05, 0.35 and 0.5 V. All the measurements were done in 500 μL of 50 mM MES (pH 5.0) and 250 mM 
NaCl. Sinusoidal waves with fixed frequency of 40 Hz for GCE and frequency of 1750 Hz for CNF NEA were 
superimposed on a DC staircase ramp from -0.05 to 0.65 V at a scan rate of 10 mV/s. The measured average AC 
current at each point was normalized by the 7.1 mm
2
 geometric surface area defined by the 3-mm i.d. O-ring. The 
real CNF surface area is ~100 times less. 
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Figure S6. (a) Background-corrected ACV peak current density ip,acv (normalized to the 7.1 mm
2
 geometric 
electrode area) of  H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NH-CH2-Fc immobilized on a VACNF NEA plotted against 
the logarithm of the frequency. (b) Background-corrected ACV peak current density ip,acv (normalized to the 7.1 mm
2
 
geometric electrode area) of  H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NH-CH2-Fc immobilized on a VACNF NEA 
plotted against the amplitude. All the measurements were done in 250 μL of 25 mM MES (pH 5.0). Note: The real 
CNF surface area is ~100 times less than the geometric surface area defined by the O-ring. 
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Figure S7. Negative control experiments. The change of the peak current (ip,acv) of H2N-(CH2)4-CO-Leu-Arg-Phe-
Gly-NH-CH2-Fc immobilized on a VACNF NEA in continuously repeated ACV measurements while (a) 25 μL of 
activation buffer consisting of 5 mM DTT and 25 mM MES (pH 5.0) and (b) the same buffer containing 9.8 ng µL
-1
 
(338 nM) deactivated cathepsin B were added into the electrochemical cell containing 250 μL of 25 mM MES (pH 
5.0). All ACV measurements were carried out at f = 800 Hz and AC voltage amplitude V0 = 150 mV. 
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Figure S8. (a) The kinetic curves of the fluorescence intensity of 0.1 ng µL
-1
 (3.45 nM) cathespin B reacting with 
different concentrations of substrate Z-Leu-Arg-AMC in 25 mM MES (pH 5.0). The cleavage between Arg and 
AMC released free AMC products which were strongly fluorescent and gave the increased fluorescence intensity. 
Inset: calibration curve of the fluorometer. (Excitation wavelength: 365 nm, emission wavelength: 410–460 nm) (b) 
The calibrated concentration of free AMC product during cathepsin B cleavage of various concentrations of 
substrate Z-Leu-Arg-AMC. 
 
Figure S9. (a) The initial proteolysis reaction rate vi of cathepsin B plotted against the starting concentration of the 
substrate Z-Leu-Arg-AMC. The reaction rate was calculated from the slope of the tangent of the initial segment of 
the curves shown in Figure S8b. (b) Replot of the data presented in (a) and derivation of various catalytic constants. 
The value of kcat/Km for cathepsin B was calculated as 2.3 x 10
4
 M
-1
s
-1
.  
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Figure S10. Negative control experiments for legumain proteolysis. The change of the peak current (ip,acv) of H2N-
(CH2)4-CO-Ala-Ala-Asn-Leu-NH-CH2-Fc immobilized on a VACNF NEA in continuously repeated ACV 
measurements (a) while 11 μL of activation buffer consisting of 50 mM CH3COONa (pH = 4.0, adjusted by adding 
acetic acid) and 100 mM NaCl was added into the electrochemical cell containing 250 μL of 50 mM MES (pH 5.0) 
and 250 mM NaCl; (b) similar experiments by including 90.9 ng µL
-1
 (1.90 μM) deactivated legumain in the 
activation buffer. All ACV measurements were carried out at f = 1750 Hz and AC voltage amplitude V0 = 150 mV.  
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Figure S11. (a) The fluorescence intensity curves of 0.5 ng µL
-1
 (10.2 nM) legumain reacting with different 
concentration of substrate Z-Ala-Ala-Asn-AMC in the assay buffer consisting of 50 mM MES (pH 5.0) and 250 mM 
NaCl. Inset: calibration curve of the fluorometer. (excitation wavelength: 365 nm, emission wavelength: 410–460 
nm). (b) The calibrated free AMC product concentration during legumain cleavage the substrate Z-Ala-Ala-Asn-
AMC.  
 
Figure S12. (a) The initial proteolysis reaction rate vi of legumain plotted against the concentration of the substrate 
Z-Ala-Ala-Asn-AMC. The reaction rate was calculated from the slope of the tangent of the initial segment of the 
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curves shown in Figure S11b. (b) Replot of the data presented in (a) and the derivation of various catalytic constants. 
The value of kcat/Km for legumain was calculated as 4.3 x 10
3
 M
-1
s
-1
.  
 
Figure S13. (a) HPLC chart of H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NHCH2Fc in 25 mM MES 
(pH 5.0) buffer. The tetrapeptide appeared at 9.4 minute in the HPLC chart and its structure was 
verified by mass spectrometry analysis. (b) HPLC chart of Phe-Gly-NHCH2Fc in 25 mM MES 
(pH 5.0) buffer. The dipeptide appeared at 6.7 minute in the HPLC chart and its structure was 
verified by mass spectrometry analysis. (c) HPLC chart of 6.35 mM H2N-(CH2)4-CO-Leu-Arg-
Phe-Gly-NHCH2Fc in 25 mM MES (pH 5.0) buffer incubated with 4.95 ng μl
-1
 (0.17 μM) 
cathepsin B for 2 hours. Absorbance peak at 6.7 minute was collected and lyophilized and mass 
spectrometry analysis showed it to be Phe-Gly-NHCH2Fc. HPLC Method: a gradient elution 
from 10% to 50% of acetonitrile in 0.1 M phosphate buffer (pH = 6) over 40 minutes was used 
with a flow rate of 10 ml/min and detection wavelength λ at 254 nm.  The column is Xperchrom 
AEGIS C18 120A 10 μm (Phenomenex). 
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Figure S14. (a) HPLC chart of H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NHCH2Fc in 50 mM MES (pH 5.0) and 250 mM 
NaCl. The tetrapeptide appeared at 9.7 minute in the HPLC chart and its structure was verified by mass spectrometry 
analysis. (b) HPLC chart of Leu-NHCH2Fc in 50 mM MES (pH 5.0) and 250 mM NaCl. The Leu-NHCH2Fc 
appeared at 12.2 min in the HPLC chart and its structure was verified by mass spectrometry analysis. (c) HPLC chart 
of 100 μM H2N-(CH2)4-CO-Ala-Ala-Asn-Leu-NHCH2Fc in 50 mM MES (pH 5.0) and 250 mM NaCl incubated with 
98.7 ng/µL (2.01 μM) legumain for 2 hours. Absorbance peak at 12.2 min was collected and lyophilized and mass 
spectrometry analysis showed it to be Leu-NHCH2Fc. HPLC Method: a gradient elution from 10% to 50% of 
acetonitrile in 0.1 M phosphate buffer (pH=6) over 40 minutes was used with a flow rate of 10 ml/min and detection 
wavelength λ at 254 nm.  The column is Xperchrom AEGIS C18 120A 10 μm (Phenomenex). 
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Experimental for Figure S13b: Synthesis of H-Phe-Gly-NHCH2-Fc for HPLC analysis.  Boc-
Gly-OH was coupled with H2N-CH2-Fc activated by HATU in DMF to yield Boc-Gly-NHCH2-
Fc. The Boc protecting group was removed using 10% TFA in dichloromethane after which the 
resulting H-Gly-NHCH2Fc was coupled with Boc-Phe-OH using EDC and DMAP as activating 
reagents in dichloromethane to furnish Boc-Phe-Gly-NHCH2-Fc. Removal of Boc protecting 
group using 10% TFA in dichloromethane gave H-Phe-Gly-NHCH2-Fc. 
Synthesis of Boc-Gly-NHCH2-Fc.  To a solution of Boc-Gly-OH (32 mg, 0.19 mmol) in dry 
DMF under argon was added HATU (77 mg, 0.20 mmol), and the resulting solution was stirred 
for 5 minutes.  To the above solution, NH2CH2-Fc (40 mg, 0.185 mmol) was added and the 
solution stirred at room temperature for 12 hours.  The reaction solution was partitioned between 
20 mL of deionized water and 20 mL of dichloromethane.  Organic layer was removed and 
aqueous layer was extracted once with 20 mL of dichloromethane.  The organic layers were 
combined and dried (MgSO4), filtered, concentrated, and column chromatographed on silica gel 
using a mixture of dichloromethane and methanol (30:1) as eluant to give 25 mg (36% yield) of 
an orange oil.  MS calc'd for C18H24FeN2NaO3 395.1 (M+Na)
+
, found to be 395.1.  
Synthesis of H-Gly-NHCH2-Fc.  To a solution of Boc-Gly-NHCH2-Fc (25 mg, 0.092 mmol) in 
4 mL of dichloromethane under argon was added 0.4 mL of trifluoroacetic acid, and the solution 
was stirred for 1 hour at room temperature.  The resulting solution was gently concentrated on a 
rotary evaporator and placed under high vacuum for 1 hour to yield a green solid.  The material is 
used in the next experiment without purification.  MS calc'd for C13H17FeN2O 273.1 (M+H)
 +
, 
found to be 273.2. 
Synthesis of Boc-Phe-Gly-NHCH2-Fc.  A solution of H-Gly-NHCH2-Fc (25 mg, 0.092 mmol) 
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(obtained from the aforementioned experiment), Boc-Phe-OH (24 mg, 0.092 mmol), 4-
(dimethylamino)pyridine (23 mg, 0.184 mmol), and 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) (35 mg, 0.184 mmol) in 1 mL of dry DMF under argon was stirred for 1 
minute at room temperature. Dry dichloromethane (2 mL) and additional DMAP (until pH of the 
reaction solution was slightly basic) were added, and the reaction solution stirred at room 
temperature for 12 hours.  The reaction mixture was partitioned between 20 mL of 
dichloromethane and 20 mL of deionized water, and 2 N hydrochloric acid was added until pH 
reached about 2. The organic layer was separated using a separatory funnel, and the aqueous layer 
was extracted four times (20 mL each) with dichloromethane.  The combined organic layers were 
washed with brine, dried (anhydrous Na2SO4), filtered, concentrated, and column 
chromatographed on silica gel using a mixture of dichloromethane and methanol (40:1) as eluant 
to give Boc-Phe-Gly-NHCH2-Fc as a yellow oil (23 mg, 48% yield).  MS calc'd for 
C27H33FeN3NaO4 542.1 (M+Na)
+
 and found to be 541.9. 
Synthesis of H-Phe-Gly-NHCH2-Fc.  A solution of Boc-Phe-Gly-NHCH2-Fc (23 mg, 0.044 
mmol) in 5 mL of 10% trifluoroacetic acid in dichloromethane was stirred at room temperature 
for 1 hour.  The reaction solution was gently concentrated on a rotary evaporator, then 20 mL of 
dichloromethane was added and concentrated again.  Addition of dichloromethane and 
subsequent concentration were repeated a total of 3 times in an effort to remove all residual 
trifluoroacetic acid.  The resulting residue was dried under vacuum to give the title compound as 
a green solid (18 mg, 98% yield). 
1
H NMR (CDCl3)  7.3 (s, 5 H), 7.12 (s, 2 H), 5.4 (s, 1 H), 4.4 
- 4.0 (m, 9 H), 3.85 (m, 2 H), 3.5 (s, 2 H), 3.2 (s, 2 H), 2.85 (s, 2 H); MS calc'd for 
C22H25FeN3NaO2 442.1 (M+Na)
+
, found to be 442.1. 
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Experimental for Figure S14b: Synthesis of H-Leu-NHCH2-Fc for HPLC analysis.  
To a solution of Fmoc-Leu-OH (126 mg, 0.36 mmol) and HATU (123 mg, 0.33 mmol) in DMF 
(1 mL) was added NH2CH2-Fc (70 mg, 0.33 mmol), and the resulting solution was stirred at 
room temperature for 30 min. It was diluted with ethyl acetate (100 mL), and the organic layer 
was washed with water (50 mL x 3) and brine (50 mL), dried (MgSO4), filtered, and concentrated 
to yield a brown oil, which was purified by silica gel chromatography using 50% EtOAc/hexane 
as eluant to give Fmoc-Leu-NHCH2-Fc (98 mg, 54% yield) as a yellow solid.  MS calc'd for 
C32H34FeN2NaO3 573.2 (M+Na)
+
, found to be 573.3.   
A solution of Fmoc-Leu-NHCH2-Fc (81 mg, 0.15 mmol) in 20% piperidine and DMF (5 mL) 
was stirred at room temperature for 30 min. DMF was removed under reduced pressure and the 
resulting crude oil was purified by column chromatography using a mixture of MeOH and EtOAc 
(5:95) as eluant to give H-Leu-NHCH2-Fc as a yellow solid (33 mg, 67% yield).  MS calc'd for 
calc'd for C17H24FeN2NaO 351.1 (M+Na)
+
, found to be 351.1. 
 
Figure S15. Comparison of cyclic voltammetric measurements of H2N-(CH2)4-CO-Ala-Ala-Asn-
Leu-NHCH2-Fc immobilized on (a) a macro-GCE and (b) a VACNF NEA. The
 52 
measurements were carried out at the scan rate of 50 mV s
-1
 in 1 mL of 1.0 M KCl.  
 
Figure S16. Preliminary specificity testing result. The change of the peak current (ip,acv) of H2N-(CH2)4-CO-Ala-
Ala-Asn-Leu-NH-CH2-Fc immobilized on a VACNF NEA in continuously repeated ACV measurements while 9.8 
ng µL
-1
 (338 nM) activated cathepsin B in 25 μL of activation buffer consisting of 5 mM DTT and 25 mM MES (pH 
5.0) was added into the electrochemical cell containing 250 μL of 25 mM MES (pH 5.0). 
 
